LYVE-1, the lymphatic system and tumor lymphangiogenesis

Previous research into hyaluronan (HA) has focused on the role of this abundant tissue glycosaminoglycan in promoting cell migration through interactions with its transmembrane receptor CD44 on inflammatory leukocytes and tumor cells. The recent discovery of a new HA receptor, LYVE-1 (lymphatic vess...

Full description

Saved in:
Bibliographic Details
Published in:Trends in immunology Vol. 22; no. 6; pp. 317 - 321
Main Authors: Jackson, David G, Prevo, Remko, Clasper, Steven, Banerji, Suneale
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01.06.2001
Subjects:
ISSN:1471-4906, 1471-4981
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Previous research into hyaluronan (HA) has focused on the role of this abundant tissue glycosaminoglycan in promoting cell migration through interactions with its transmembrane receptor CD44 on inflammatory leukocytes and tumor cells. The recent discovery of a new HA receptor, LYVE-1 (lymphatic vessel endothelial HA receptor), expressed predominantly in lymphatic vessels, highlights another aspect of HA biology: its continuous transit through the lymphatic system and its potential involvement in lymph node homing by CD44 + leukocytes and tumor cells. The functional role of LYVE-1 in lymphatic vessels and its application as a marker to study tumor lymphangiogenesis are important areas of investigation.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1471-4906
1471-4981
DOI:10.1016/S1471-4906(01)01936-6